594 related articles for article (PubMed ID: 19433464)
21. N-acetyltransferase 2, exposure to aromatic and heterocyclic amines, and receptor-defined breast cancer.
Rabstein S; Brüning T; Harth V; Fischer HP; Haas S; Weiss T; Spickenheuer A; Pierl C; Justenhoven C; Illig T; Vollmert C; Baisch C; Ko YD; Hamann U; Brauch H; Pesch B;
Eur J Cancer Prev; 2010 Mar; 19(2):100-9. PubMed ID: 19996973
[TBL] [Abstract][Full Text] [Related]
22. NAT2, GSTM-1, cigarette smoking, and risk of colon cancer.
Slattery ML; Potter JD; Samowitz W; Bigler J; Caan B; Leppert M
Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1079-84. PubMed ID: 9865425
[TBL] [Abstract][Full Text] [Related]
23. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction.
Marcus PM; Hayes RB; Vineis P; Garcia-Closas M; Caporaso NE; Autrup H; Branch RA; Brockmöller J; Ishizaki T; Karakaya AE; Ladero JM; Mommsen S; Okkels H; Romkes M; Roots I; Rothman N
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):461-7. PubMed ID: 10815690
[TBL] [Abstract][Full Text] [Related]
24. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
Cascorbi I; Roots I; Brockmöller J
Cancer Res; 2001 Jul; 61(13):5051-6. PubMed ID: 11431340
[TBL] [Abstract][Full Text] [Related]
25. Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of cigarette smoking and systemic lupus erythematosus in a Japanese population.
Kiyohara C; Washio M; Horiuchi T; Asami T; Ide S; Atsumi T; Kobashi G; Takahashi H; Tada Y;
Scand J Rheumatol; 2012 Mar; 41(2):103-9. PubMed ID: 22217397
[TBL] [Abstract][Full Text] [Related]
26. Impact of N-acetyltransferase polymorphism (NAT2) in hepatocellular carcinoma (HCC)--an investigation in a department of surgical medicine.
Farker K; Schotte U; Scheele J; Hoffmann A
Exp Toxicol Pathol; 2003 Jun; 54(5-6):387-91. PubMed ID: 12877350
[TBL] [Abstract][Full Text] [Related]
27. Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population.
Rouissi K; Ouerhani S; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; El Gaaied AB
Cancer Genet Cytogenet; 2009 Apr; 190(2):101-7. PubMed ID: 19380028
[TBL] [Abstract][Full Text] [Related]
28. GSTT1, GSTM1, GSTM3 and NAT2 polymorphisms in laryngeal squamous cell carcinoma in a Greek population.
Chatzimichalis M; Xenellis J; Tzagaroulakis A; Sarof P; Banis K; Gazouli M; Bibas A
J Laryngol Otol; 2010 Mar; 124(3):318-23. PubMed ID: 19922706
[TBL] [Abstract][Full Text] [Related]
29. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.
Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC
Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012
[TBL] [Abstract][Full Text] [Related]
30. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
[TBL] [Abstract][Full Text] [Related]
31. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
Stern MC; Johnson LR; Bell DA; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
[TBL] [Abstract][Full Text] [Related]
32. NAT2*7 allele is a potential risk factor for adult brain tumors in Taiwanese population.
Liu HE; Hsiao PY; Lee CC; Lee JA; Chen HY
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):661-5. PubMed ID: 18349284
[TBL] [Abstract][Full Text] [Related]
33. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
34. N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men.
Hamasaki T; Inatomi H; Katoh T; Aono H; Ikuyama T; Muratani T; Matsumoto T
Int J Urol; 2003 Mar; 10(3):167-73. PubMed ID: 12622714
[TBL] [Abstract][Full Text] [Related]
35. N-acetyltransferase 2 polymorphism in patients with diabetes mellitus.
Yalin S; Hatungil R; Tamer L; Ates NA; Dogruer N; Yildirim H; Karakas S; Atik U
Cell Biochem Funct; 2007; 25(4):407-11. PubMed ID: 16397907
[TBL] [Abstract][Full Text] [Related]
36. Sequence variants of NAT1 and NAT2 and other xenometabolic genes and risk of lung and aerodigestive tract cancers in Central Europe.
McKay JD; Hashibe M; Hung RJ; Wakefield J; Gaborieau V; Szeszenia-Dabrowska N; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Mates D; Foretova L; Janout V; Bencko V; Chabrier A; Hall J; Boffetta P; Canzian F; Brennan P
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):141-7. PubMed ID: 18199719
[TBL] [Abstract][Full Text] [Related]
37. NAT2 fast acetylator genotype is associated with an increased risk of lung cancer among never-smoking women in Taiwan.
Chiou HL; Wu MF; Chien WP; Cheng YW; Wong RH; Chen CY; Lin TS; Lee H
Cancer Lett; 2005 Jun; 223(1):93-101. PubMed ID: 15890241
[TBL] [Abstract][Full Text] [Related]
38. Para-phenylenediamine and allergic sensitization: risk modification by N-acetyltransferase 1 and 2 genotypes.
Blömeke B; Brans R; Coenraads PJ; Dickel H; Bruckner T; Hein DW; Heesen M; Merk HF; Kawakubo Y
Br J Dermatol; 2009 Nov; 161(5):1130-5. PubMed ID: 19663877
[TBL] [Abstract][Full Text] [Related]
39. Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant mesothelioma.
Betti M; Neri M; Ferrante D; Landi S; Biava A; Gemignani F; Bertolotti M; Mirabelli D; Padoan M; Ugolini D; Botta M; Bonassi S; Magnani C; Dianzani I
Int J Hyg Environ Health; 2009 May; 212(3):322-9. PubMed ID: 18838334
[TBL] [Abstract][Full Text] [Related]
40. Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma.
Moslehi R; Chatterjee N; Church TR; Chen J; Yeager M; Weissfeld J; Hein DW; Hayes RB
Pharmacogenomics; 2006 Sep; 7(6):819-29. PubMed ID: 16981843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
